Dr. Deidre L. Church

University Position

Clinical Interests

Graduating Year

University of Calgary, 1978

Residency/Fellowship

Recent Publications

  1. Twele L, E Moyen, J Kim, B Dalton, K Zhang, D Church and J Conly. Methicillin-resistant Staphylococcus aureus (MRSA) endocarditits and de novo development of Daptomycin resistance during therapy. (in preparation).
  2. Vanderkooi O, DL Church, J MacDonald, G Tyrrell and JD Kellner. Trends in antimicrobial resistance of invasive and lower respiratory tract Streptococcus pneumoniae (SP) isolates in Calgary Canada, 1998-2006. (In preparation)
  3. Miller, B, H Baxter, T. Lloyd, S Elsayed, and DL Church. Evaluation of StrepB Carrot BrothTM vs. LIM broth for determining Group B Streptococcus (GBS) colonization status of near-term pregnant women. J Clin Microbiol (Submitted).
  4. Campbell L, T Lloyd, S Elsayed, and DL Church. Evaluation of the OSOMÒ Trichomonas rapid test (OSOMÒ ) versus microscopic examination of wet mount preparations for diagnosis of T. vaginalis vaginitis in a regional clinical microbiology laboratory. J Clin Microbiol (Submitted).
  5. Pitout, JD, DB Gregson, DL Church and Laupland KB. In vitro activity of Tigecycline and Ertapenem against well-characterized multiresistant CTX-M-producing Escherichia coli. J Antimicrob Chemother (Submitted).
  6. Church DL, KB Laupland, D Zygun, G van Marle and MJ Gill. Gut HIV-1 infection and longitudinal survival analysis in a cohort of HIV-1 seropositive men prior to HAART. J Infect Dis (Submitted).
  7. Laupland KB, DB Gregson, DL Church, TRoss and JD Pitout. 2008. Incidence, risk factors, and outcomes of Escherichia coli blood stream infections in a large Canadian Region. Clin Microbiol Infect (In press).
  8. Janvier J, S Kuhn and DL Church. 2008. A Case of Pseudomembranous Colitis in a Patient with Systemic Lupus Erythematosis. Can J Infect Dis (In press).
  9. Pitout JD, Y Wie, DL Church and DB Gregson. 2008. Surveillance for plasmid-mediated quinolone resistance determinants in in Enterobacteriaceae within the Calgary Health Region, Canada: The emergence of aac (6)-Ib-cr. J Antimicrob Chemother (In press).
  10. Pitout JD, DL Church and P Nordmann. 2008. Occurrence of an SME-2-producing Serratia marcescens isolate in Canada. Int J Antimicrob Agents; 31:181-2. [Epub 2007 Dec. 20].
  11. van Marle G, MJ Gill, D Kolodka, L McManus, T Grant and DL Church. 2007. Compartmentalization of the gut viral reservoir in HIV-1 infected patients. Retrovirology Dec 4;4(1):87 [Epub ahead of print].
  12. Laupland KB, MD Parkins, DB Gregson, DL Church, T Ross, and JC Pitout. 2007. Population-based surveillance for Serratia species isolates in a large Canadian health region. Eur J Clin Microbiol Infect Dis Oct 25; [Epub ahead of print].